| Metric | Current Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue | ¥447.7B | ¥422.0B | +6.1% |
| Operating Income | ¥29.1B | ¥22.9B | +27.2% |
| Equity-Method Investment Income (Loss) | - | - | - |
| Ordinary Income | ¥30.1B | ¥24.6B | +22.2% |
| Net Income | ¥20.5B | ¥16.6B | +23.7% |
| ROE | 4.4% | 3.8% | - |
For the cumulative Q2 of FY2026, Revenue was ¥447.7B (YoY +¥25.7B +6.1%), Operating Income was ¥29.1B (YoY +¥6.2B +27.2%), Ordinary Income was ¥30.1B (YoY +¥5.5B +22.2%), and Net Income was ¥20.5B (YoY +¥3.9B +23.7%), representing revenue and profit growth. Operating margin improved to 6.5% from 5.4% in the prior year period (+1.1pt), indicating notable profitability improvement. Gross margin rose to 17.0% from 16.1% (+0.9pt), and SG&A ratio declined to 10.5% from 10.7% (-0.2pt), demonstrating effective operating leverage. Progress against the full-year plan stands at Revenue 51.5%, Operating Income 67.7%, Ordinary Income 66.9%, and Net Income 66.2%, indicating profits are materially front-loaded well above the typical 50% mid-year level.
Revenue of ¥447.7B (+6.1%) remained solid. By segment, core Japan was ¥377.7B (+5.6%) representing 84.4% of total, Americas grew to ¥67.5B (+22.6%), and Asia Pacific achieved ¥28.1B (+11.6%)—both double-digit growth. Conversely, China declined materially to ¥15.9B (-34.1%), showing regional divergence. The revenue mix remains Japan-dependent and thus sensitive to domestic demand. On the profit side, Cost of Goods Sold was ¥371.6B, 83.0% of Revenue, producing Gross Profit of ¥76.1B (Gross Margin 17.0%), up from 16.1% (+0.9pt), suggesting product mix improvement and price revisions. SG&A was ¥47.0B (10.5% of Revenue), contained to +3.9% YoY below revenue growth (+6.1%), allowing operating leverage to work. Operating Income was ¥29.1B (+27.2%), Operating Margin 6.5% (prior 5.4%, +1.1pt). Non-operating items contributed +¥1.0B (interest income ¥0.6B, dividend income ¥0.3B, etc.), resulting in Ordinary Income of ¥30.1B (+22.2%). Extraordinary items were negligible, yielding Profit Before Tax ¥30.1B, income taxes ¥9.6B (effective tax rate 31.8%), and Net Income ¥20.5B (+23.7%). Comprehensive Income was ¥38.0B, ¥17.5B higher than Net Income, driven by foreign currency translation adjustments ¥12.0B and valuation differences on available-for-sale securities ¥5.4B. In conclusion, revenue and profit increased, and margins expanded across stages due to improvements in gross margin and operating performance.
Japan: Revenue ¥377.7B (+5.6%), Operating Income ¥21.7B (+47.6%), Operating Margin 5.8%, the core segment contributing 74.6% of consolidated profit. Americas: Revenue ¥67.5B (+22.6%) showing high growth, but Operating Income ¥3.0B (-44.1%) and Operating Margin deteriorated to 4.4%, suggesting cost increases and low-margin projects. Asia Pacific: Revenue ¥28.1B (+11.6%), Operating Income ¥4.2B (+31.8%), Operating Margin 14.8%—highly profitable on a smaller scale. China: Revenue ¥15.9B (-34.1%), Operating Loss ¥0.3B (-44.0%) remaining in the red, reflecting a challenging market. Other: Revenue ¥4.1B (+35.0%) but Operating Loss ¥0.2B (-286.7%). Overall, Japan and Asia Pacific drive profitability, while Americas and China dilute margins. Significant profitability dispersion across regions means Americas recovery and China return to profitability are key priorities.
Profitability: Operating Margin 6.5% (prior 5.4%, +1.1pt), Net Profit Margin 4.6% (prior 3.9%, +0.7pt) showing margin improvement. ROE 4.4% (prior 3.8%) decomposed as Net Profit Margin 4.6% × Total Asset Turnover 0.62x × Financial Leverage 1.55x. ROE remains below the industry median of 6.9%, leaving room for improvement in absolute profitability. Gross Margin 17.0% improved from 16.1% but is still low, making the company sensitive to price competition and cost overruns. EBITDA was ¥34.9B (Operating Income ¥29.1B + Depreciation ¥5.8B), with an EBITDA margin of 7.8%. Cash Quality: Operating Cash Flow (OCF) was -¥38.7B, and OCF/Net Income was -1.88x, indicating poor cash quality driven by working capital. Major drivers were decrease in accounts payable (-¥52.3B), increase in accounts receivable (-¥19.3B), and decrease in contract liabilities (-¥16.8B), causing working capital to move counter-cyclically. Cash Conversion (OCF/EBITDA) was -1.11x, well below the industry median of 1.13x. Investment Efficiency: Total Asset Turnover improved to 0.62x (prior 0.57x), above the industry median 0.45x. Inventory Days were 95 days, Days Sales Outstanding (DSO) 103 days, and Days Payable Outstanding 88 days, yielding an approximate Working Capital Turnover of 110 days, roughly in line with the industry median ~123 days but worsened YoY. Financial Health: Equity Ratio 64.4% (prior 58.6%, +5.8pt) materially above the industry median 40.0%, indicating strong capitalization. Financial Leverage 1.55x (prior 1.71x) is conservative vs industry median 2.34x, implying low financial risk. Current Ratio 248% and Quick Ratio 207% show ample liquidity; cash and deposits ¥249.5B exceed short-term liabilities ¥235.5B. Interest-bearing debt is minimal, and Interest Coverage is 4161x (EBITDA ¥34.9B / Interest Expense ¥0.01B), indicating extremely high resilience to interest burden.
Operating Cash Flow was a large negative -¥38.7B, a deterioration of -¥59.6B from prior year +¥21.0B. With Net Income ¥20.5B, OCF/Net Income was -1.88x, demonstrating weak cash generation. Operating cash flow before working capital changes (subtotal) was -¥30.4B; even adding back Depreciation ¥5.8B leaves a negative, indicating core cash generation issues. Working capital headwinds included decrease in accounts payable -¥52.3B, increase in accounts receivable -¥19.3B, and decrease in contract liabilities -¥16.8B. Inventory contributed +¥16.9B (from inventory decrease), but could not offset other working capital deterioration. Corporate tax payments -¥9.3B also reduced cash, resulting in a significant negative OCF. Investing Cash Flow was -¥8.4B, mainly acquisitions of tangible and intangible assets -¥6.8B. Capex/Depreciation ratio ~1.17x indicates continued growth investment. Proceeds from sale of securities +¥2.0B partially offset investing outflows. Free Cash Flow was -¥47.0B (OCF -¥38.7B + Investing CF -¥8.4B), substantially negative, failing to cover dividends -¥9.1B and minimal share buybacks, funded from cash on hand. Financing Cash Flow was -¥9.3B, primarily dividends. Cash decreased by -¥49.3B during the period to end cash ¥249.5B (prior ¥296.4B). While liquidity risk is low given ample cash, normalizing working capital (improving payables, receivables, and contract liabilities) is the top priority to restore cash quality.
Recurring income constitutes the majority of profit; extraordinary items were negligible (Extraordinary Gain ¥0.02B from sale of fixed assets, Extraordinary Loss ¥0.03B from disposal), indicating earnings are driven by core operations. Non-operating income ¥1.5B is small at 0.3% of Revenue and comprised of interest income ¥0.6B, dividend income ¥0.3B, forex gains ¥0.2B, etc. Non-operating expenses ¥0.5B were mainly forex losses ¥0.5B, so net non-operating contribution +¥1.0B is within normal range. The ¥9.6B difference between Ordinary Income ¥30.1B and Net Income ¥20.5B is explained by income taxes (effective rate 31.8%), a normal tax burden. Comprehensive Income ¥38.0B exceeds Net Income by ¥17.5B, driven by foreign currency translation adjustments ¥12.0B and valuation gains on securities ¥5.4B—non-cash valuation gains that have not been monetized. Accrual Ratio (Net Income - OCF) / Total Assets is 8.2%, in a neutral-to-somewhat-caution range; OCF materially below Net Income signals concerns over cash quality. Depreciation ¥5.8B and goodwill amortization ¥0.02B are minor non-cash charges, so most of EBITDA ¥34.9B stems from Operating Income. Recurring income quality is high, but delayed cash conversion from working capital partially impairs earnings quality.
The full-year plan remains unchanged: Revenue ¥870.0B (+1.0%), Operating Income ¥43.0B (-5.2%), Ordinary Income ¥45.0B (-6.4%), Net Income ¥31.0B. Cumulative Q2 progress is Revenue 51.5%, Operating Income 67.7%, Ordinary Income 66.9%, and Net Income 66.2%, indicating profits are front-loaded ~17pt above a standard 50% mid-year pace. Management maintains a conservative stance without revising guidance, likely factoring in front-loaded costs, seasonality, delayed improvement in Americas profitability, and continued China losses. Conversely, if first-half gross margin improvements and operating leverage persist and partial normalization of working capital occurs, there is upside to the full-year plan. Dividend forecast is annual ¥62, consistent with the interim dividend; implied payout ratio on full-year Net Income forecast is 26.8% (based on Net Income ¥31.0B), within a reasonable range.
Interim dividend ¥62 (prior ¥56), giving a payout ratio of 40.5% against cumulative Q2 EPS ¥153.14. Progress toward full-year dividend forecast ¥62 is 100%, effectively confirming annual dividend ¥62. Based on company Net Income forecast ¥31.0B, total dividends ~¥8.3B imply a payout ratio of 26.8%, within a reasonable range. Share buybacks are negligible (-¥0.006B), indicating a dividend-centric return policy. Total Return Ratio is roughly in line with the payout ratio at ~26.8%. With Free Cash Flow -¥47.0B and dividend payments -¥9.1B, FCF coverage is -5.2x and insufficient, but strong cash balance ¥249.5B and conservative capitalization (Equity Ratio 64.4%) provide capacity to pay dividends. In the short term, as long as working capital-driven cash pressure persists, dividends will rely on cash on hand; if working capital normalizes and OCF turns positive in H2, dividend sustainability will improve materially. Dividend policy is stable and, supported by improving profitability and financial strength, shareholder returns are assessed as sustainable.
Industry positioning (reference — company analysis): Compared with the trading industry median for Q2 2025, Equity Ratio 64.4% exceeds the industry median 40.0% by 24.4pt, highlighting financial strength. Total Asset Turnover 0.62x exceeds the industry median 0.45x, indicating relatively good asset efficiency. However, ROE 4.4% is -2.5pt below the industry median 6.9%, placing profitability below peers. Net Profit Margin 4.6% is -2.4pt below the industry median 7.0%, indicating room for margin improvement. Cash Conversion (OCF/EBITDA) -1.11x is well below the industry median 1.13x, placing cash quality among the weakest in the industry. Inventory Days 95 days are roughly in line with the industry median 94 days. Receivables Days 103 days are shorter than the industry median 160 days, indicating relatively good collection efficiency. Payables Days 88 days are shorter than the industry median 128 days, representing a shorter payment cycle and a working capital pressure point. Financial Leverage 1.55x is substantially below the industry median 2.34x, reflecting a conservative financial posture. Overall, the company outperforms industry on financial resilience and asset efficiency but lags on profitability and cash quality. Improving cash quality and margins is key to enhancing relative industry positioning.
Key points to watch in the earnings are as follows. First, improvement in Operating Margin to 6.5% (prior 5.4%, +1.1pt) and Gross Margin to 17.0% (prior 16.1%, +0.9pt) suggests product mix improvements and operating leverage are starting to work. Full-year progress in Operating Income at 67.7% indicates higher-margin projects and efficiency gains in H1, but sustainability in H2 is the focal point. Second, material deterioration in cash quality with OCF -¥38.7B and OCF/Net Income -1.88x is notable. Accounts payable -¥52.3B and contract liabilities -¥16.8B indicate working capital reversal likely due to timing mismatches in orders/acceptance or changes in payment terms. Despite cash ¥249.5B and strong capitalization, normalizing working capital (shortening DSO and DIO, stabilizing payables and contract liabilities) is the top priority. Third, regional earnings imbalance: Japan accounts for 74.6% of profit, creating concentration risk; Americas Operating Income -44.1% and China Operating Loss ¥0.3B remain challenges. Asia Pacific’s high margin 14.8% is notable but small in scale; expanding geographic diversification and improving Americas/China profitability are keys to medium-term growth. Payout ratio 40.5% (interim) and full-year 26.8% are appropriate, and backed by strong financials, shareholder returns are likely sustainable.
This report is an earnings analysis automatically generated by AI analyzing XBRL financial statement data. It is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the company from public financial statements. Investment decisions are your responsibility; please consult a professional if necessary.